Reveto Pharmaceuticals Private Limited

Reveto Pharmaceuticals Private Limited - chemicals in Rajura, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2016PTC286758 Incorporated 13 October 2016 ROC Nagpur HQ Rajura, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2021
₹1.87 Lakh
▲ 53% YoY
Net profit · FY 2021
₹3,903
Net margin 2.1%
EBITDA · FY 2021
₹5,788
EBITDA margin 3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
Last financials
Mar 2021
Balance sheet date

About Reveto Pharmaceuticals Private Limited

Data last updated:

Reveto Pharmaceuticals Private Limited is a private limited company based in Rajura, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 13 October 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2016PTC286758.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dhananjay Balwant Bobde and Mohd Shadab Mohd Ilyas.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Shri K.K.Bobde At Post Rajura Dl Dl – 3644 Gadchandur Road Nr Saikrupa, Medical, Maharashtra, India – 442402.

As per the financials filed for FY 2021, the company reported a revenue of ₹1.87 Lakh, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹3,903 (net margin 2.1%) and EBITDA of ₹5,788 (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH2016PTC286758
Registration Number 286758
Incorporation Date 13 October 2016
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant

Contact details

Reveto Pharmaceuticals Private Limited's registered office is in Rajura, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Shri K.K.Bobde At Post Rajura Dl Dl – 3644 Gadchandur Road Nr Saikrupa, Medical, Maharashtra, India – 442402
  • Industry
    Chemicals, Other Chemical Product, Manufacturing

To see the full contact details of Reveto Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Reveto Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Reveto Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Reveto Pharmaceuticals Private Limited, buy the company report.

Financials of Reveto Pharmaceuticals Private Limited

FY 2021 filings available

Reveto Pharmaceuticals Private Limited reported revenue of ₹1.87 Lakh (up 53% YoY) for FY 2021.

Revenue · FY 2021
₹1.87 Lakh ▲ 53%
Net profit · FY 2021
₹3,903 margin 2.1%
EBITDA · FY 2021
₹5,788 margin 3.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▼ 25%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 18%

Revenue rose 53% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 25%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5,788
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3,903
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin3.1%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Reveto Pharmaceuticals Private Limited, buy the company report.

Board of directors of Reveto Pharmaceuticals Private Limited

Reveto Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dhananjay Balwant BobdeDirector13 Oct 201610 Years 0 MonthsCurrent
Mohd Shadab Mohd IlyasDirector13 Oct 201610 Years 0 MonthsCurrent
Ganesh Dhonduji KakadeDirector13 Oct 201610 Years 0 MonthsCurrent

Shareholding

The shareholding of Reveto Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Reveto Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Reveto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Reveto Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Reveto Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Dhananjay Balwant Bobde was appointed as Director on 13 Oct 2016.

AGM
Reveto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Reveto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Nagpur.
Appointed
Dhananjay Balwant Bobde was appointed as Director.
Appointed
Ganesh Dhonduji Kakade was appointed as Director.
Appointed
Mohd Shadab Mohd Ilyas was appointed as Director.
Incorporation
13 Oct 2016
Reveto Pharmaceuticals Private Limited was registered on 13 Oct 2016 with Roc Nagpur & aged 10 years 26 days as per MCA records.

Frequently asked questions

Reveto Pharmaceuticals is an active private limited company based in Rajura, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 13 October 2016 (10+ years old) and is registered under CIN U24230MH2016PTC286758.

Reveto Pharmaceuticals has 3 current directors:

The latest financial statements of Reveto Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.

The CIN (Corporate Identification Number) of Reveto Pharmaceuticals is U24230MH2016PTC286758. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Reveto Pharmaceuticals was incorporated on 13 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.

Dhananjay Balwant Bobde was appointed as Director on 13 Oct 2016. Ganesh Dhonduji Kakade was appointed as Director on 13 Oct 2016. Mohd Shadab Mohd Ilyas was appointed as Director on 13 Oct 2016.

The registered office of Reveto Pharmaceuticals is at Shri K.K.Bobde At Post Rajura Dl Dl – 3644 Gadchandur Road Nr Saikrupa, Medical, Maharashtra, India – 442402.

Reveto Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

The compliance status of Reveto Pharmaceuticals is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.

Reveto Pharmaceuticals can be reached at its registered office: Shri K.K.Bobde At Post Rajura Dl Dl – 3644 Gadchandur Road Nr Saikrupa, Medical, Maharashtra, India – 442402.